Premier Alternatives

GT Medical Technologies

Tempe, AZ · Founded 2017 · Privately Held (backing)

Developer of a medical therapeutic device designed to overcome the limitations of current treatments by placing it after the tumor removal. GT Medical Technologies is based in Tempe, AZ and was founded in 2017. It was valued at $215 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $161 million across 6 recorded rounds; the latest was a $53.3 million later-stage round in Dec 2024.

PMV mark · valuation
$215.3M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$161.5M
Last round
Later Stage VC
Dec 2024

GT Medical Technologies key facts

as of Oct 2026
  • Developer of a medical therapeutic device designed to overcome the limitations of current treatments by placing it after the tumor removal.
  • GT Medical Technologies is valued at approximately $215.3M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $161.5M across 6 recorded rounds; the latest was Later Stage VC ($53.3M) in Dec 2024.
  • Notable investors include MedTech Innovator, Gilde Healthcare, Arizona Commerce Authority, FemHealth Ventures, Flinn Foundation — 18 tracked in total.
  • GT Medical Technologies has filed 8 Form Ds with the SEC since 2017, most recently Jun 2025 ($53.3M sold to 37 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$215.3M

Valued at $215.3M at its later-stage round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of GT Medical Technologies with a free account
  • ·The complete investor list: 18 names
  • ·Watch GT Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GT Medical Technologies funding rounds

6 rounds
Dec 2024Later Stage VC$53.3MSEC filing▮
Mar 2023Early Stage VC$37.4MSEC filing▮
Nov 2020Early Stage VC$15.5MSEC filing▮
Nov 2018Early Stage VC$5.6MSEC filing▮
Dec 2017Seed Round$1.9MSEC filing▮
Full funding history →

GT Medical Technologies valuation

GT Medical Technologies was valued at $215 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has GT Medical Technologies raised?

GT Medical Technologies has raised $161 million across 6 recorded rounds since 2017. The largest was a $5.6 million early-stage round in Nov 2018; the most recent was a $53.3 million later-stage round in Dec 2024.

GT Medical Technologies has filed 8 Form Ds with the SEC since 2017, most recently in Jun 2025 ($53.3 million sold to 37 investors).

GT Medical Technologies investors

18 investors are on record for GT Medical Technologies, including MedTech Innovator, Gilde Healthcare, Arizona Commerce Authority and FemHealth Ventures. The later-stage round in Dec 2024 drew 37 investors.

About GT Medical Technologies

Developer of a medical therapeutic device designed to overcome the limitations of current treatments by placing it after the tumor removal. The company's device features a bioresorbable, conformable, collagen tile and a uniform radiation source that utilizes advanced brachytherapy techniques, minimizing radiation exposure to healthy tissue, reducing side effects, and decreasing treatment burden, enabling medical practitioners to prevent disease progression and improving the quality of life for their patients.

Sector
Healthcare
HQ
Tempe, AZ, United States
Founded
2017
Employees
100
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.